ECP 2022 Final Programme

Tuesday, 6 Sept 55 Scientific Programme a Tuesday ECP 2022 Basel OFP-10 Oral Free Paper Session 08:30–12:00 Shanghai Oral Free Paper Session Breast Pathology Chairs: Janina Kulka, Hungary Thomas Decker, Germany 001 08:30–08:40 Mucoepidermoid carcinoma of the breast: multidimensional profiling reveals novel biomarkers and genetic drivers Mariia Ivanova, Italy K. Venetis, E. Sajjadi, S. Andaloro, C. Rossi, M. Lucioni, U. Malapelle, F. Pagni, M. Barberis, E. Guerini Rocco, G. Viale, N. Fusco 002 08:40–08:50 Association of metastatic pattern in breast cancer with tumour type and patient specific factors: a nationwide autopsy study using artificial intelligence Fatemeh Kazemzadeh, The Netherlands A. Snoek, Q. Voorham, N. Hugen, M. van Oijen, I. Nagtegaal 003 08:50–09:00 Automated prognosis marker assessment in 2’004 breast cancers using an artificial intelligence-based framework for BLEACH&STAIN mfIHC Guido Sauter, Germany T. Mandelkow, E. Bady, J. Müller, N. Debatin, M. Lurati, C. Hube-Magg, N. Blessin 004 09:00–09:10 Upgrade rate and predictive factors for benign breast intraductal papilloma on core biopsy in Vancouver, Canada Taylor Salisbury, Canada S. Koonmee, L. Ali, O. Ondic, R. Bhan, K. Pivovarcikova, A. Gurung, R. Alaghehbandan 005 09:10–09:20 Evaluation of dual color-dual in-situ hybridization (D-DISH) for HER2/neu testing in breast cancer Sangeeta Desai, India A. Rathi, P. Shah, A. Sahay, A. Patil, T. Shet 006 09:20–09:30 Image-based identification of HER2 status in H&E-stained breast cancer slides Orli Greenberg, Israel A. Zubkov, L. Trejo, D. Nataf, I. Hayun, A. Avinoam, I. Gazy, N. Paz-Yaacov, Dov Hershkovitz 008 10:30–10:40 Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) Chiara Villa, Italy P. Rainone, M. Cadamuro, S. Valtorta, S. Todde, R. Moresco, M. Lavitrano 009 10:40–10:50 Challenges of breast NEN: NEN G3 and genetic analysis Yueping Liu, China M. Zhao 010 10:50–11:00 Prediction of the efficacy of neoadjuvant therapy for breast cancer with immunologic and genome characteristics Yueping Liu, China M. Han 011 11:00–11:10 Histological assessment of large fresh breast surgical specimens with ultra-fast slide-free confocal microscopy: a feasibility study Marie-Christine Mathieu, France M. Ragazzi, M. Ferchiou, P. Van Diest, O. Casiraghi, M. Nap, A. Ben Lakhdar, N. Labaied, A. Conversano, M. Abbaci 012 11:10–11:20 PIK3CA mutations in endocrine-resistant breast cancer Caroline Schagerholm, Sweden S. Robertson, B. Holm, H. Awier, H. Toosi, E. Sifakis, J. Hartman 013 11:20–11:30 Breast carcinoma with apocrine differentia- tion: less indolent than expected? Chiara Rossi, Italy S. Fraticelli, E. Boveri, G. Di Giulio, M. Fanizza, B. Francesco, A. Sgarella, A. Ferrari, A. Della Valle, E. Ferraris, A. Lasagna, G. Rizzo, E. Bonzano, M. Paulli, M. Lucioni 014 11:30–11:40 Claudin-1 expression in triple-negative breast cancers (TNBCs) and its clinical significance Abderrahman Ouban, Saudi Arabia